Literature DB >> 23218931

Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty.

Emmanuel Guilbert1, Julien Bullet, Otman Sandali, Elena Basli, Laurent Laroche, Vincent M Borderie.   

Abstract

PURPOSE: To identify risk factors for corneal graft rejection and rejection irreversibility.
DESIGN: Retrospective cohort study.
METHODS: setting: Institutional. patients: A total of 1438 consecutive eyes of 1438 patients who underwent corneal transplantation for optical indication at the Centre Hospitalier National d'Ophtalmologie des XV-XX, Paris, France, between December 1992 and December 2010 were studied. Surgical technique was penetrating keratoplasty (PK) in 1209 cases, anterior lamellar keratoplasty (ALK) in 165 cases, and Descemet stripping with endothelial keratoplasty in 64 cases. main outcome measures: Cumulative incidence of rejection episodes and rejection irreversibility rate.
RESULTS: A total of 299 cases of rejection episodes were identified, of which 145 (48.5%) were irreversible after treatment. In multivariate analysis, the cumulative incidence of rejection episodes was influenced by recipient age (P = .00002), recipient rejection risk (P = .0003), lens status (P = .00003), and surgical group (P = .035). A higher incidence of rejection episodes was observed in young patients (<20 years) and patients aged from 41 to 50, high-risk recipients, aphakic eyes and eyes with anterior chamber intraocular lens, and eyes with PK (compared with eyes with ALK). Rejection episodes were more likely to be irreversible for high-risk recipients (P = .02), for eyes with preoperative hypertony (P = .009), and for eyes with poor visual acuity at presentation (P = .002).
CONCLUSIONS: Recipient rejection risk and surgical group are the main risk factors for rejection as they both influence the incidence of rejection and the reversibility rate. Recipient age and lens status are predictive factors for the occurrence of rejection. Preoperative hypertony is a predictive factor for rejection irreversibility.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218931     DOI: 10.1016/j.ajo.2012.09.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Update on the Management of High-Risk Penetrating Keratoplasty.

Authors:  Sayena Jabbehdari; Alireza Baradaran Rafii; Ghasem Yazdanpanah; Pedram Hamrah; Edward J Holland; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2017-02-02

Review 2.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

3.  Effect of dexamethasone intravitreal implant in a corneal graft rejection.

Authors:  Nilufer Yesilirmak; Evin Singar Ozdemir; Dilek D Altinors
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

Review 4.  Therapeutic implications of nanomedicine for ocular drug delivery.

Authors:  Tuo Meng; Vineet Kulkarni; Russell Simmers; Vikram Brar; Qingguo Xu
Journal:  Drug Discov Today       Date:  2019-05-15       Impact factor: 7.851

5.  Descemet Membrane Thickening as a Sign for the Diagnosis of Corneal Graft Rejection: An Ex Vivo Study.

Authors:  Ryan VanDenBerg; Vasilios F Diakonis; Alison Bozung; Gustavo Rosa Gameiro; Oliver Fischer; Ahmed El Dakkak; Jan Paul Ulloa-Padilla; Apostolos Anagnostopoulos; Sander Dubovy; Mohamed Abou Shousha
Journal:  Cornea       Date:  2017-12       Impact factor: 2.651

6.  Evolving Techniques in Corneal Transplantation.

Authors:  Grace E Boynton; Maria A Woodward
Journal:  Curr Surg Rep       Date:  2015-02-01

7.  In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection.

Authors:  Mohamed Abou Shousha; Sonia H Yoo; Mohamed S Sayed; Sean Edelstein; Matthew Council; Ravi S Shah; Joshua Abernathy; Zachary Schmitz; Patrick Stuart; Rocio Bentivegna; Maria P Fernandez; Christopher Smith; Xiaotang Yin; George J Harocopos; Sander R Dubovy; William J Feuer; Jianhua Wang; Victor L Perez
Journal:  Am J Ophthalmol       Date:  2017-03-02       Impact factor: 5.258

Review 8.  Mucosal vaccine delivery: A focus on the breakthrough of specific barriers.

Authors:  Mengwen Huang; Miaomiao Zhang; Hongbin Zhu; Xiaojiao Du; Jun Wang
Journal:  Acta Pharm Sin B       Date:  2022-07-06       Impact factor: 14.903

Review 9.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

10.  Corneal Allograft Rejection: Immunopathogenesis to Therapeutics.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  J Clin Cell Immunol       Date:  2013-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.